CAFFARRA, Paolo
 Distribuzione geografica
Continente #
EU - Europa 13.230
NA - Nord America 7.122
AS - Asia 6.046
SA - Sud America 781
AF - Africa 266
Continente sconosciuto - Info sul continente non disponibili 99
OC - Oceania 15
Totale 27.559
Nazione #
IT - Italia 9.194
US - Stati Uniti d'America 6.876
SG - Singapore 2.259
CN - Cina 1.626
VN - Vietnam 781
IE - Irlanda 642
BR - Brasile 594
SE - Svezia 577
DE - Germania 501
NL - Olanda 489
FI - Finlandia 481
HK - Hong Kong 452
UA - Ucraina 349
FR - Francia 317
TR - Turchia 282
ZA - Sudafrica 188
CA - Canada 186
GB - Regno Unito 185
BD - Bangladesh 173
IN - India 125
CH - Svizzera 117
RU - Federazione Russa 79
AT - Austria 70
AR - Argentina 65
JP - Giappone 46
ES - Italia 43
PH - Filippine 42
IQ - Iraq 35
EC - Ecuador 33
BE - Belgio 32
MX - Messico 32
ID - Indonesia 28
PL - Polonia 28
PK - Pakistan 27
RO - Romania 26
TH - Thailandia 25
TW - Taiwan 24
MA - Marocco 18
PY - Paraguay 16
IR - Iran 15
CL - Cile 14
CO - Colombia 14
LT - Lituania 14
PE - Perù 14
VE - Venezuela 14
AU - Australia 12
EG - Egitto 12
PT - Portogallo 11
SA - Arabia Saudita 10
AL - Albania 9
GR - Grecia 9
JO - Giordania 9
KR - Corea 9
MY - Malesia 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
HU - Ungheria 8
KE - Kenya 8
CI - Costa d'Avorio 7
IL - Israele 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
BO - Bolivia 6
DZ - Algeria 6
RS - Serbia 6
SM - San Marino 6
BG - Bulgaria 5
EU - Europa 5
TN - Tunisia 5
BH - Bahrain 4
CR - Costa Rica 4
ET - Etiopia 4
GY - Guiana 4
HN - Honduras 4
JM - Giamaica 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
OM - Oman 4
QA - Qatar 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
SC - Seychelles 3
SI - Slovenia 3
SN - Senegal 3
AO - Angola 2
BW - Botswana 2
MO - Macao, regione amministrativa speciale della Cina 2
SV - El Salvador 2
Totale 27.445
Città #
Singapore 1.061
Milan 986
Rome 698
Ashburn 661
Chandler 660
Dublin 641
San Jose 637
Jacksonville 576
Santa Clara 567
Beijing 496
Hong Kong 420
Ho Chi Minh City 283
Naples 260
Council Bluffs 246
Izmir 236
Dearborn 220
Dallas 205
Boardman 202
Nanjing 194
Bologna 190
Verona 189
Turin 185
Johannesburg 175
Hanoi 174
Princeton 152
Florence 150
San Mateo 149
Parma 146
Ann Arbor 143
Padova 141
Lauterbourg 137
New York 127
Genoa 116
Los Angeles 111
Bari 106
Catania 98
Wilmington 96
Palermo 95
Toronto 88
Shanghai 76
Cagliari 72
Nanchang 72
Helsinki 69
São Paulo 65
Vienna 64
Woodbridge 63
Trieste 62
Des Moines 61
Hebei 60
Trento 54
Shenyang 53
Brescia 51
Moscow 49
Munich 46
Kunming 45
Padua 45
Venice 45
Modena 44
Jinan 43
Columbus 42
Monza 41
Bremen 40
Pescara 39
Ancona 37
Tianjin 37
Buffalo 35
Perugia 34
Hefei 33
Pavia 33
Da Nang 32
Changsha 30
Frankfurt am Main 30
Jiaxing 30
Taranto 29
Haiphong 28
Ottawa 28
Phoenix 27
Vicenza 27
Mumbai 26
Brussels 25
Guangzhou 25
Udine 25
Houston 24
Torino 24
Busto Arsizio 22
Genova 22
Messina 22
Pisa 22
Brooklyn 21
Hangzhou 21
Napoli 21
Rio de Janeiro 21
Salerno 21
Tokyo 21
Amsterdam 20
Treviso 20
Carpi 19
Chieti 19
Latina 19
San Genesio Ed Uniti 19
Totale 14.267
Nome #
Una versione abbreviata del test di Stroop: dati normativi nella popolazione italiana. 7.205
A short version of the Stroop test: Normative data in an Italian population sample 2.265
Italian norms for the Freedman version of the Clock Drawing Test. 1.061
Modified Card Sorting Test: normative data 320
ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease 218
Visuo-spatial imagery impairment in posterior cortical atrophy: a cognitive and SPECT study. 180
The hormonal pathway to cognitive impairment in older men. 178
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 176
Brain structural substrates of semantic memory decline in Mild Cognitive Impairment. 174
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 173
ACTH/Cortisol involvement in the serotonergic disorder affecting the parkinsonian brain. 168
Functional Disability in Early Alzheimer’s Disease – A Validation Study of the Italian Version of the Disability Assessment for Dementia Scale 168
The qualitative scoring MMSE pentagon test (QSPT): A new method for differentiating dementia with Lewy Body from Alzheimer's disease. 166
"Benign recurrent vertigo" and its connection with migraine. 163
The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up 162
Abnormal serotoninergic control of prolactin and cortisol secretion in patients with seasonal affective disorder 161
A case of reversible anti-NMDA-receptor encephalitis: neuropsychological and neuroradiological features 159
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 158
Behavioural and cognitive impairment in Parkinson-Dementia and Alzheimer type Dementia., 7, 116,1993. 157
Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorders. 155
Effects of dog-assisted therapies on cognitive mnemonic capabilities in people affected by Alzheimer's disease 155
Benign recurrent vertigo and its connection with migraine 154
A 6-month, double blind placebo-controlled trial of Eptastigmine in Alzheimer’s disease. Dement Geriatr Cogn Disord 2000;11:17-24 152
ApoE genotype and cognitive functions in Alzheimer’s disease. Alzheimer’s Research 151
Influence of APOE status on lexical-semantic skills in Mild Cognitive Impairment 150
A normative study of a shorter version of the Raven Progressive Matrices 1938. 149
Degenerative jargon aphasia: unusual progression of logopenic/phonological progressive aphasia? 148
Normalità e patologia delle funzioni cognitive nell’invecchiamento. 146
[A case of multiple cerebrovascular and migraine episodes caused by the use of oral contraceptives]. 146
A multicenter Italian randomised study on early treatment of Parkinson disease:comparison of l-dopa, l-deprenyl and dopaminoagonists. Study design and short term results. 143
Efficacia di un programma di stimolazione cognitiva sulle funzioni cognitive e sul metabolismo cerebrale in pazienti con malattia di Alzheimer: dati preliminari di uno studio in aperto 141
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 141
Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders. A multicenter Italian clinical cross-sectional study on 431 patients. 139
Clinical and Cognitive Phenotype of Mild Cognitive Impairment Evolving to Dementia with Lewy Bodies 139
Shortened stroop color-word test: its application in normal aging and Alzheimer's disease. Neurobiol.Aging 1992;13;1;3-4 137
Age at onset and SPECT imaging in Alzheimer's disease. 136
Neurofunctional correlates of changes of semantic abilities in Mild Cognitive Impairment (MCI): preliminary results. 133
[Complicated migraine]. 132
Rey-Osterreith Complex Figure: Normative values in an Italian population sample. 131
Explorative study on the cognitive and functional predictors of slow versus rapid disease progression in Alzhiemr's Disease. 130
Semantic Memory Impairment and Neurofunctional Alterations in Mild Cognitive Impairment 130
A Validation study of the Italian version of the disability assessment for dementia in patients with Alzheimer’s disease. 127
Cognitive demand and reminders effect on prospective memory in MCI patients. 123
[Transitory topographical amnesia]. 123
Clinical salience of visuospatial memory and structural brain deficits in Mild Cognitive Impairment 123
Increased Functional Connectivity in the Default Mode Network in Mild Cognitive Impairment: A Maladaptive Compensatory Mechanism Associated with Poor Semantic Memory Performance 122
Diagnostic flow chart for the atypical variants of dementia 120
Utilità e limiti della tomografia ad emissione di fotoni (SPECT) nella Malattia di Alzheimer. 119
MRI multimodal investigation on a small cohort of patients affected by amnestic Mild Cognitive Impairment. 119
L’attivazione cognitiva del paziente demente. In La riabilitazione neuropsicologica. Masson, Milano 1999; 385-394. 118
L’utilizzo delle reti neurali nella diagnosi differenziale neuropsicologica fra la Demenza a Corpi di Lewy e la Malattia di Alzheimer. 117
Cognitive demand and reminders effect on time-based prospective memory in amnesic Mild Cognitive Impairment (aMCI) and in healthy elderly 117
Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment 116
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer’s disease. 115
Transient topographical amnesia. 115
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 115
Relationship between spatial ability, visuospatial working memory and self-assessed spatial orientation ability: a study in older adults. 115
Brief practical clinical diagnostic criteria for the neurodegenerative diseases in the elderly 115
Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder. Biol.Psychiatry;35:36-41;1994 115
High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies 115
Failure of oxytocin to affect motor performance in Parkinson's disease. J.Neurol.1985;(suppl.232);133 114
Il cervello non si “riposa” 114
Semiquantitive assessment of regional cerebral perfusion using 99mTc HM-PAO and emission tomography. 113
Normalità e patologia delle funzioni cognitive nell’invecchiamento. 113
ALEXIA WITHOUT AGRAPHIA OR HEMIANOPIA 113
Cognitive demand and reminders effect on prospective memory in MCI patients 112
Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder 109
Oxytocin enhances thyrotropin-releasing-hormone-induced prolactin release in normal mestruting women 109
Reduction in the arginine vasopressin responses to metoclopramide and insulin-induced hypoglicemia in normal weight bulimic women. 109
Effect of substance P on basal and TRH-stimulated TSH release in humans 108
Oxytocin enhances thyrotropin-releasing hormone-induced prolactin release in normal menstruating women. 108
Cervical pain and odynophagia as unusual presentation of reumathoid arthritis 108
L'audizione dicotica in epilettici temporali con o senza lesioni accertabili. 108
Transient Global Amnesia and migraine. 108
Decreased drug-cue induced attentional bias in individuals with treated and untread drug dependence 107
Stereotypic behaviors in degenerative dementias. 106
Differenze emisferiche nei tempi di reazione semplici in pazienti depressi unipolari non-psicotici. 106
Visuospatial planning and problem solving in Alzheimer's disease patients: a study with the Tower of London Test 105
Lack of ACTH/cortisol and GH responses to intravenously-infused Substance P in Parkin¬son's disease. 105
Recovery from transient global amnesia following restoration of hippocampal and fronto cingulate perfusion 104
Failure of the gamma-aminobutyric acid (GABA) derivative, baclofen, to stimulate growth hormone secretion in Parkinson's disease. 104
Tower of London Test: a comparison between conventional statistic approach and modelling based on artificial neural network in differentiating fronto-temporal dementia from Alzheimer’s disease 104
The MMSE pentagon copying is more impaired in Lewy Body dementia than Alzheimer’s Disease. 103
Evaluation of regional cerebral blood flow using 99mTc-HM-PAO and Single Photon Emission Tomography (SPECT) 103
Osservazioni sulla percezione cutanea degli stimoli tattili figurati nell'uomo in condizioni normali. 103
Opioid control of pituitary function in parkinsonian patients before and after dopaminergic therapy 103
Discriminant function analysis of Fuld's formula and WAIS subtests in different types of dementia 103
Neural basis of endogenous and exogenous spatial orienting: a functional MRI study. 101
Perseverative dysgraphia: a selective disorder in writing double letters 100
Orienting of visual attention in Alzheimer’s disease. Its implication in favor of the interhemispheric balance. 99
Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects 99
Fuld's formula and WAIS subtests in differential diagnosis of dementia 99
Reduced ACTH/cortisol responses to naloxone in men with Parkinson's disease. 99
Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease 99
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. 98
Neuropsychological testing during a transient global amnesia episode and its follow-up. 97
Project Cronos: multiple version of the Mini Mental State Examination ? 97
Italian group for Lewy Body dementia (LBD): presentation of first data collected. 96
I riflessi in Neurologia. 96
Permanent amnesia due to bilateral hipppocampal lesion: report of a clinical case. 96
Totale 22.977
Categoria #
all - tutte 71.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.074 0 42 37 65 63 48 123 156 103 99 66 272
2022/20233.256 309 280 198 233 260 355 69 237 887 106 207 115
2023/20242.540 165 172 126 208 177 288 230 222 214 237 263 238
2024/20255.702 213 309 500 444 605 663 346 340 642 509 376 755
2025/20268.442 743 725 843 686 1.088 544 941 403 1.137 547 456 329
2026/2027811 332 479 0 0 0 0 0 0 0 0 0 0
Totale 27.559